For more than two decades, the biomedical company Pfizer has been working in the research and development of treatments to respond to the unmet medical needs of people living with rare diseases.

You can learn more about it here:

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like Technology that is changing the face of first line healthcare Empowering doctors in rare disease diagnosis Mendelian receives over €570k for its rare disease diagnostics by Innovate UK

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian

Learn more